Episode 20 – EAACI 2024 reflections
An episode of the All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit podcast, hosted by ACARE, the Global Allergy and Asthma Excellence Network for Angioedema, titled "Episode 20 – EAACI 2024 reflections" was published on June 18, 2024 and runs 21 minutes.
June 18, 2024 ·21m · All Things Angioedema – Learning about angioedema with Dr. Thomas Buttgereit
Summary
Dr Thomas Buttgereit asks Dr Clemens Schöffl about EAACI Congress 2024 highlights, which include early data on outcomes of CRISPR-based gene editing of KLKB1 in people with HAE. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/. Additional resources relating to the topics discussed in this episode can be found here: EAACI Congress 2024 – Breakthroughs in management of hereditary angioedema; CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema; Clinical experience with berotralstat in patients with hereditary angioedema with normal C1-esterase inhibitor: A commented case series.
Episode Description
Similar Episodes
Apr 1, 2026 ·46m
Mar 30, 2026 ·15m
Mar 5, 2026 ·28m